Gastric cancer remains a critical public health issue globally, with new statistics from the National Cancer Center indicating about 514,000 new cases in ...
Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...
The open-label study assessed CT041-ST-01, also known as satricabtagene autoleucel or satri-cel, a cell therapy ... 1 pancreatic cancer trial and a phase 1b/2 trial for advanced gastric or ...
A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue-some as ...
Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from its Phase I/II CLINCH study ongoing in China and Australia evaluating ATN-022 ...
Previously, clinical research findings on cadonilimab in the treatment of various malignancies have been published in internationally renowned journals such as The Lancet, The Lancet Oncology, Nature ...